Our Shanghai facility plays an important role in our globally leading biopharmaceutical
contract manufacturing business and embodies our continuous and long-term commitment to China," said Hubertus von Baumbach, chairman of the board of managing directors, Boehringer Ingelheim.
The clincher for Vienna was ultimately the companys desire to additionally secure the market supply of biopharmaceutical
products and to balance the risk by establishing a further independent facility.
BioPartners, Baar, Switzerland, a privately-owned biopharmaceuticals
company has expressed disappointment that its biosimilar Interferon Alpha, Alpheon(R), had received a negative opinion from the European Medicines Agency's Committee on Medicinal Products for Human Use (CHMP).
WASHINGTON -- The Generic Pharmaceutical Association says "sound science" supports the marketing of generic biopharmaceuticals
, and it has called on the Food and Drug Administration to accelerate the approval of affordable biopharmaceuticals
In China, the veterinary vaccine belongs to not the biopharmaceutical
industry but the realm of the veterinary drug.
The Global Biopharmaceutical
Industry has come a long way since its first drug- Humulin was approved in 1982.
The author spent two months to interview a large number of China's biopharmaceutical
manufacturers and wrote this report depending on abundant second-hand information.
In 2008, the market size of China's biopharmaceutical
industry was about 70 billion Yuan (about 10 billion US Dollars), where the growth rate passed the whole market size of China's medicine market and also above three sub-sectors including chemical medicine materials, chemical medicine dose and traditional Chinese prepared medicines.
The report has analyzed China's biopharmaceutical
industry in terms of production and sales, import and export, sub-sectors and development trend.
Compared with traditional pharmaceutical industry, biopharmaceutical
industry sees a higher market concentration, and this is more helpful for strong enterprises to grow stronger and for building a number of leading enterprises in the segment areas.
William Downey, President of HighTech Business Decisions, explains, "We extensively interviewed 41 directors of biomanufacturing at pharmaceutical and biotechnology companies worldwide, and 27 biopharmaceutical
is a biopharmaceutical
company focused on the development of late-stage "disruptive" clinical products, especially for already-approved drugs in new formulations and/or new indications that are patent-protected and which represent new therapeutics with greater clinical and economic value.